Ex parte ANIMATI et al. - Page 2




                 Appeal No. 95-2727                                                                                                                     
                 Application 07/699,898                                                                                                                 



                                      2                                                                                                                 
                          Claims 1 , 21, 22, and 54 are illustrative of the subject matter on appeal and                                                
                 read as follows:                                                                                                                       
                          1.  An 8-fluoroanthracycline-glycoside compound of the formula (I). [sic, :]                                                  













                 where:                                                                                                                                 
                 R = H, OH, or OR”;                                                                                                                     
                 R  = H, OH, or OCH ;1                     3                                                                                                           
                 R” = CHO-COCH  or an acyl residue derived from a carboxylic acid containing up to 6                                                    
                                        3                                                                                                               
                 carbon atoms; and [sic, -] NH  indicates that the amino substituent can be in the axial                                                
                                                         2                                                                                              
                 or equatorial configuration; or a pharmaceutically acceptable salt thereof.                                                            

                          21.  A pharmaceutical composition comprising a therapeutically effective amount                                               
                 of an anthracyclineglycoside of formula I in accordance with claim 1, or a                                                             
                 pharmaceutically acceptable salt thereof, in mixture with a pharmaceutically acceptable                                                
                 diluent or carrier.                                                                                                                    

                          2The amendment filed on March 12, 1993 which was approved for entry by the                                                    
                 examiner has not been physically entered in the file.  The examiner should attend to                                                   
                 this matter upon return of the application.  The copies of claims 1, 21 and 54 are as                                                  
                 these claims were amended in that paper.  Also, the copy of claim 1 notes the                                                          
                 typographical errors contained in that claim as amended in that paper.                                                                 
                                                                           2                                                                            





Page:  Previous  1  2  3  4  5  Next 

Last modified: November 3, 2007